Walgreen Boots Stock Price, News & Analysis

Blazing Star Merger Sub, Inc. announced early tender results for Walgreens Boots Alliance (NASDAQ: WBA)'s previously announced cash tender offers and consent solicitation for multiple series of senior notes. As of the Early Tender Deadline on August 4, 2025, the company received significant participation across all note series, with tender rates ranging from 83% to 98% of outstanding principal amounts.

The tender offer is connected to WBA's pending acquisition through a merger agreement dated March 6, 2025, where Blazing Star Parent, LLC will acquire WBA. The company has received the requisite consents for proposed amendments to the indentures. The tender offer is scheduled to expire on August 18, 2025, with settlement expected on August 19, 2025, coinciding with the merger closing.

Walgreens (NYSE:WBA) has launched nationwide flu shot appointments for individuals aged three and older, with both walk-in and scheduled vaccination options available. The company is enhancing its vaccination services with digital check-in features and the ability to schedule multiple vaccines in a single visit for up to four people.

Starting August 1, myWalgreens members will receive 20% off their next eligible purchase with any vaccine. The announcement comes as pharmacy-administered flu vaccines nearly doubled to 38 million doses in 2024-2025 compared to 22 million doses in medical offices. The CDC data indicates that the 2024-2025 flu season was notably severe, marking the first such occurrence since 2017-2018.

Blazing Star Merger Sub, Inc. has launched tender offers for any and all outstanding notes of Walgreens Boots Alliance (NASDAQ: WBA) and Walgreen Co., spanning multiple series with various interest rates and maturities from 2025 to 2050. The tender offers are accompanied by consent solicitations to modify certain indenture provisions.

The tender offer includes an Early Tender Payment of $50 (or €50/£50 for European notes) per $1,000 principal amount for holders who tender by August 4, 2025. The offer expires on August 18, 2025, with settlement expected on August 19, 2025. This initiative is directly connected to WBA's pending acquisition via merger with Blazing Star Parent, LLC.

Walgreens (NYSE:WBA) has announced a new healthcare collaboration with Premier Medical to establish in-store medical clinics in Central Florida. The partnership will initially launch with two clinics opening in July 2025 in Davenport and Orlando, Florida.

The clinics will provide primary care, chronic condition management, and dermatology services to patients with Medicare, Medicare Advantage, commercial, and select Medicaid plans. Premier Medical, part of NeueHealth, plans to expand with additional clinic locations later in the year.

Walgreens Boots Alliance (Nasdaq: WBA) shareholders have overwhelmingly approved the company's acquisition by Sycamore Partners, with 96% of total votes and 95% of unaffiliated shareholder votes in favor of the merger agreement.

Under the deal terms, shareholders will receive $11.45 per share in cash at closing, plus a non-transferable Divested Asset Proceeds Right for up to an additional $3.00 per share from the future monetization of WBA's interests in VillageMD. The transaction is expected to close in Q3 or Q4 of 2025, pending regulatory approvals.

Walgreens Boots Alliance (NASDAQ:WBA) reported disappointing Q3 fiscal 2025 results, with sales increasing 7.2% to $39.0 billion but posting a loss of $0.20 per share compared to earnings of $0.40 in the year-ago quarter. Adjusted EPS fell to $0.38 from $0.63 last year.

The company's performance was marked by weakness in U.S. front-end sales, with retail sales declining 5.3%. However, pharmacy sales increased 11.8% and comparable pharmacy sales grew 14.6%. The U.S. Healthcare segment showed improvement, turning an adjusted operating loss of $22 million last year into a $54 million profit.

Notably, WBA has entered into a definitive agreement to be acquired by Sycamore Partners, with the transaction expected to close in Q3 or Q4 of calendar year 2025. As a result, the company has withdrawn its fiscal 2025 guidance.

Walgreens (WBA) and KFF's Greater Than Campaign are organizing the largest-ever National HIV Testing Day event on June 27, 2025, offering free HIV, syphilis, and hepatitis C testing at over 575 Walgreens locations. The initiative involves more than 415 local health departments and community organizations across the US, DC, and Puerto Rico. This marks the partnership's highest participation in its 15-year history, having provided over 93,000 free HIV/STD tests since 2011. The testing will be conducted in private areas with results available within 20 minutes. Leading manufacturers have donated over 22,000 rapid test kits. Walgreens pharmacists receive HIV prevention training, with 3,000 specialists having completed advanced HIV treatment education. The campaign is supported by major public health organizations and includes awareness efforts through Mesmerize's advertising network.

LiveRamp (NYSE: RAMP) has announced a strategic partnership with Walgreens Advertising Group (WAG) to power their clean room solution. The collaboration enhances WAG's ability to leverage first-party data from over 101 million myWalgreens loyalty members, offering advertisers improved audience targeting, activation, and measurement capabilities. Key features include self-service access to audience creation, expanded data collaboration, activation across multiple platforms, and consolidated measurement with granular insights. The partnership focuses on data portability, audience scalability, and campaign measurability while maintaining privacy protections. WAG advertisers can now better utilize Walgreens' extensive customer base data generated from online, in-store, and delivery activities to create more personalized targeting across various media channels.

Walgreens (WBA) has opened a new micro-fulfillment center (MFC) in Brooklyn Park, Minnesota, expanding its automated prescription processing network. The facility will support nearly 200 Midwest stores, including 145 in Minnesota, and is expected to process approximately 13 million prescriptions annually. The center will create over 175 local jobs.

This addition brings Walgreens' MFC network to 12 facilities nationwide, supporting over 5,000 stores and processing more than 3.5 million prescriptions weekly. The network has shown impressive results, including a 24% year-over-year increase in shipped volumes and managing approximately 40% of prescription volume for supported stores. The initiative also includes an environmental focus, having recycled 3.7 million pounds of materials in fiscal 2024.